These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 7901243)
21. Understanding and treating dyslipidemia associated with noninsulin-dependent diabetes mellitus and hypertension. McKenney JM Pharmacotherapy; 1993; 13(4):340-52. PubMed ID: 8361860 [TBL] [Abstract][Full Text] [Related]
22. [Revival of antihypertensive therapy: use of thiazide diuretics]. Nagy V Orv Hetil; 2004 Mar; 145(13):669-76. PubMed ID: 15125317 [TBL] [Abstract][Full Text] [Related]
23. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization. Xie F; Petitti DB; Chen W Am J Hypertens; 2005 Apr; 18(4 Pt 1):464-9. PubMed ID: 15831354 [TBL] [Abstract][Full Text] [Related]
24. Possible biochemical mechanisms involved in the antihypertensive drug-induced changes in serum lipoproteins. Lijnen P; Fagard R; Staessen J; Amery A Methods Find Exp Clin Pharmacol; 1989 Jan; 11(1):17-23. PubMed ID: 2654525 [TBL] [Abstract][Full Text] [Related]
25. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients. Ybarra J; James RW; Makoundou V; Bioletto S; Golay A Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380 [TBL] [Abstract][Full Text] [Related]
26. Combined effect of captopril and thiazide diuretic on serum lipid profile in hypertensive women. Karim S; Karim S; Begum A; Javed N J Ayub Med Coll Abbottabad; 2001; 13(1):19-21. PubMed ID: 11706633 [TBL] [Abstract][Full Text] [Related]
27. The place of diuretics in preventing cardiovascular events. Kaplan NM J Hum Hypertens; 2004 Dec; 18 Suppl 2():S29-32. PubMed ID: 15592570 [TBL] [Abstract][Full Text] [Related]
28. [Antihypertensive agents and serum lipids]. Helgeland A Tidsskr Nor Laegeforen; 1981 Sep; 101(25):1406-7. PubMed ID: 6122289 [No Abstract] [Full Text] [Related]
29. Effects of celiprolol and other antihypertensive agents on serum lipids and lipoproteins. Hunninghake DB Am Heart J; 1991 Feb; 121(2 Pt 2):696-701. PubMed ID: 1671189 [TBL] [Abstract][Full Text] [Related]
30. [Molecular mechanism of fatty acids impact on plasma lipid profile (part I)]. Swierczyński J; Wołyniec W; Chmielewski M; Rutkowski B Przegl Lek; 2007; 64(1):37-41. PubMed ID: 18183830 [TBL] [Abstract][Full Text] [Related]
31. [Very low density lipoproteins and subclasses of intermediate density lipoproteins in postmenopausal women]. Berg G; Halperín H; Siseles N; Wikinski R Medicina (B Aires); 1996; 56(5 Pt 1):479-86. PubMed ID: 9239883 [TBL] [Abstract][Full Text] [Related]
32. Management of hypercholesterolaemia in the patient with diabetes. Packard C; Olsson AG Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606 [TBL] [Abstract][Full Text] [Related]
33. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Hadaegh F; Harati H; Ghanbarian A; Azizi F Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):571-7. PubMed ID: 16874147 [TBL] [Abstract][Full Text] [Related]
34. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046 [TBL] [Abstract][Full Text] [Related]
35. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292 [TBL] [Abstract][Full Text] [Related]
36. Effects of lipoproteins from pre-eclamptic women on umbilical endothelial cell 6-oxo-prostaglandin f1alpha and endothelin 1 synthesis, and nitric oxide synthase 3 mRNA expression. Barden A; Beilin LJ; Both K; Ritchie J; Leedman P; Walters BN; Michael CA Clin Sci (Lond); 1999 Dec; 97(6):697-706. PubMed ID: 10585897 [TBL] [Abstract][Full Text] [Related]
37. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism. Nash DT Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236 [TBL] [Abstract][Full Text] [Related]
38. Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment. Rabkin SW J Clin Pharmacol; 1993 Mar; 33(3):286-91. PubMed ID: 8096525 [TBL] [Abstract][Full Text] [Related]
39. Lipid profile studies in long term thiazide treated hypertensives. Rao RA; Hegde BM; Bhat EK; Vidyavathi U; Rao RR Postgrad Med J; 1991 Jul; 67(789):652-4. PubMed ID: 1924051 [TBL] [Abstract][Full Text] [Related]